EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

ADVANCES IN THE DEVELOPMENT OF VACCINE AGAINST DIFFERENT SARS CoV-2 VARIANTS

Shivangi Saxena*, Srishti Katiyar, Abhay Kumar, Archan Gupta, Shalini Yadav and Pushpendra Kumar

ABSTRACT

The coronavirus 2 that causes the severe acute respiratory syndrome, a worldwide disease that has caused devastation on public health, human lives, and the global economy. Vaccination is regarded as one of the most significant breakthroughs during medical history. Based on past SARS-CoV vaccine development experience, All COVID-19 vaccinations should be investigated for both protective advantages and potential risks eosinophilic infiltration and/or increased infectivity may come from antibody-dependent enhancement. This is regarded as the world leader in SARS-CoV-2 vaccine research, the Sinopharm CNBG initiating the most current international clinical investigation in the UAE. We discuss recent developments in vaccine research against SARS-CoV-2 clinically relevant strains, such initiatives, it is predicted, would contribute in the developments of effective and economical SARS-CoV-2 vaccine.

Keywords: .

[Full Text Article] [Download Certificate]